At the Precision Human Health Laboratory (PHHL), we are committed to advancing clinical research to improve the understanding and management of chronic diseases.
Here are highlights of our ongoing projects:
Investigating pulmonary vascular function and the effects of vasodilators like sildenafil in healthy individuals and those with chronic pulmonary diseases. Using tools such as the tilt table, Treprostinil, and lower body pressure devices, this project examines fluid shifts, DLCO, and sex, fitness, and clinical phenotype-based differences to better understand pulmonary circulation and its role in health and disease.
Using MRI to measure pulmonary transit time—how long blood takes to travel through the pulmonary circulation—and the multiple inert gas elimination technique (Inert Gas) to assess how well airflow and blood flow are matched in the lungs. These complementary approaches help us understand oxygen exchange at rest and during exercise.
Examining how cannabis smoking and e-cigarette use affect lung function, blood vessels, and exercise responses. Our research aims to characterize physiological differences associated with these exposures and better understand their implications for cardiopulmonary health.
Investigating blood flow and oxygen delivery in people with chronic kidney disease, including those receiving hemodialysis. Using near-infrared spectroscopy and diffuse correlation spectroscopy (NIRS-DCS), alongside MRI, we examine vascular function and its relationship with exercise intolerance.
The University of Alberta, its buildings, labs and research stations are primarily located on the territory of Néhiyaw (Cree), Niitsitapi (Blackfoot), Métis, Nakoda (Stoney), Dene, Haudenosaunee (Iroquois) and Anishinaabe (Ojibway/Saulteaux), lands that are now known as part of Treaties 6, 7 and 8 and homeland of the Métis. The University of Alberta respects the sovereignty, lands, histories, languages, knowledge systems and cultures of all First Nations, Métis, and Inuit.